within Pharmacolibrary.Drugs.ATC.C;

model C01AB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.002,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01AB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Proscillaridin is a cardiac glycoside derived from plants of the Scilla genus. It was historically used as a cardiotonic agent for the treatment of congestive heart failure and certain arrhythmias. However, due to its narrow therapeutic index and the availability of safer alternatives, proscillaridin is rarely used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Parameters represent an estimate for an adult human after oral administration, as no published human pharmacokinetics studies with full parameter sets could be identified for proscillaridin.</p><h4>References</h4><ol><li><p>Andersson, KE, et al., &amp; Wettrell, G (1977). Proscillaridin activity in portal and peripheral venous blood after oral administration to man. <i>European journal of clinical pharmacology</i> 11(4) 277–281. DOI:<a href=\"https://doi.org/10.1007/BF00607677\">10.1007/BF00607677</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/862648/\">https://pubmed.ncbi.nlm.nih.gov/862648</a></p></li><li><p>Belz, GG, et al., &amp; Wolf, GK (1976). Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man. <i>European journal of clinical pharmacology</i> 10(2) 101–108. DOI:<a href=\"https://doi.org/10.1007/BF00609467\">10.1007/BF00609467</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/786669/\">https://pubmed.ncbi.nlm.nih.gov/786669</a></p></li><li><p>Belz, GG (1974). Proceedings: Studies on pharmacokinetics of proscillaridin-4&#x27;-methyl ether in man. <i>Naunyn-Schmiedeberg&#x27;s archives of pharmacology</i> 282(Suppl) R7–None. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/4276519/\">https://pubmed.ncbi.nlm.nih.gov/4276519</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01AB01;
